Contract for the supply of meningococcal ACWY vaccine

The provision of a vaccine for the prevention of invasive meningococcal disease caused by Neisseria meningitidis groups A, C, W and Y, to be used as part of the national immunisation programme. The contracting authority estimates their requirement over the period of the contract, including the period of the optional extension to be up to 3 500 000 doses of vaccine. Additional information: This future opportunity was originally published 5 February 2016 under the Commercial Medicines Unit as the contact organisation...